Keyword: Johnson & Johnson


J&J Ends Mosaico HIV Vaccine Trial on poor Results

27.01.2023 -

Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...


GenScript Raises $224 Million in Fresh Capital

25.01.2023 -

In its third fundraising round in less than two years, Hong Kong-listed globally active CDMO giant GenScript Biotech has netted a fresh $224 million capital injection...


J&J to Pull Talc-based Baby Powder Worldwide

16.08.2022 -

Johnson & Johnson is finally pulling the plug on its iconic talc-based baby powder worldwide.


FDA Restricts Use of J&J Covid Vaccine

13.05.2022 -

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...


J&J and Distributors Finalize Opioid Settlements

28.02.2022 -

US healthcare giant Johnson & Johnson and three major distributors, AmerisourceBergen, Cardinal Health and McKesson, have finalized a long-negotiated nationwide...


Novavax and J&J with Vaccine Delivery Delays

09.02.2022 -

As wealthy countries with ample supplies of Covid-19 vaccine struggle to convince more people to get the shot, and poorer countries struggle to nail down supplies, two US...


Johnson & Johnson to Split Consumer from Pharma

15.11.2021 -

Another US healthcare business is being split into separate parts or separated from other parts of a diverse group. First General Electric, with its health segment, went...


Aspen Close to Covid Vaccine License Deal with J&J

01.11.2021 -

South Africa's Aspen Pharmacare aims to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses per year by February 2024, from 250 to 300 million doses...